Therapeutic Value of Sirolimus in Refractory Adult-Onset Still's Disease

NCT07151157 · clinicaltrials.gov ↗

NA

Phase

ACTIVE_NOT_RECRUITING

Status

3

Enrollment

OTHER

Sponsor class

Conditions

Adult-Onset Still's Disease

Interventions

DRUG: add-on sirolimus therapy

Sponsor

Ruijin Hospital